SD Biosensor, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
SD Biosensor, Inc. - overview
Established
2008
Location
Suwon-si, Gyeonggi-do, South Korea
Primary Industry
Medical Devices & Equipment
About
Founded in 2008 and based in Suwon-si, South Korea, SD Biosensor, Inc. , specializes in providing and manufacturing diagnostic products such as blood glucose meters, COVID-19 kits, antigen testers, saliva home tests, and other healthcare analyzer kits for various diseases. As of 2022, the company is led by its President and Chief Executive Officer, Tae young Heo. The company offers various medical devices and diagnostic test equipment that include Pilot™ COVID-19 at-home test, standard lipidocare analyzer, standard G6PD Analyzer, d-block Incubator, MultiCare™ system, a reflectometry immunoassay instrument, and many more.
Primary Industry
Medical Devices & Equipment
Sub Industries
Monitoring Equipment, Diagnostic Equipment, Medical Software
Website
www.sdbiosensor.com
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
SD Biosensor, Inc. - financials
| Fiscal Year Ended | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 36,298,831,910 | 44,643,516,776 | 54,257,150,532 | 65,633,389,424 | 73,728,081,333 | 1,686,163,033,272 | 2,929,960,839,878 | - | - | - |
| % Revenue Growth (YoY) | - | 23.0% | 21.5% | 21.0% | 12.3% | 2187.0% | 73.8% | - | - | - |
| EBITDA (USD) | 7,165,890,029 | 4,126,655,150 | 2,534,087,960 | 7,444,706,225 | 5,408,850,510 | 738,272,473,514 | 1,383,155,255,912 | - | - | - |
| Operating Income (USD) | 4,080,466,417 | 406,509,568 | (1,618,249,740) | 3,039,752,606 | 895,456,609 | - | 1,364,040,578,912 | - | - | - |
| Operating Margin | 11.2% | 0.9% | (3.0%) | 4.6% | 1.2% | - | 46.6% | - | - | - |
| % EBITDA Margin | 19.7% | 9.2% | 4.7% | 11.3% | 7.3% | 43.8% | 47.2% | - | - | - |
| NET Income (USD) | 5,059,805,610 | 1,401,089,899 | (3,295,830,524) | 3,031,673,983 | 1,398,744,414 | 621,613,859,262 | 1,064,432,159,915 | - | - | - |
| % Net Margin | 13.9% | 3.1% | (6.1%) | 4.6% | 1.9% | 36.9% | 36.3% | - | - | - |
SD Biosensor, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Public to Private, Secondary Buyout | Completed | Meridian Bioscience, Inc. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.